Influence of hydroxypropyl-β-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone

Drug Development and Industrial Pharmacy

Volumn 28, Issue 9, 2002, Pages 1117-1124

  Felton, Linda A ^a   Wiley, Cody J ^a   Godwin, Donald A ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Complexation; Hydroxypropyl cyclodextrin; Oxybenzone; Reservoir; Skin accumulation; Transdermal permeation

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; OXYBENZONE; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BENZOPHENONE DERIVATIVE; BETA CYCLODEXTRIN DERIVATIVE; CYCLODEXTRIN; EXCIPIENT; SOLVENT; SUNSCREEN; WATER;

ANIMAL TISSUE; APPARATUS; ARTICLE; CALCULATION; CHEMICAL REACTION; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG PENETRATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID; MOUSE; NONHUMAN; REACTION ANALYSIS; SKIN ABSORPTION; SKIN PENETRATION; TIME; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; HAIRLESS MOUSE; IN VITRO STUDY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; PERMEABILITY; SKIN; SOLUBILITY; THERMODYNAMICS;

ADMINISTRATION, CUTANEOUS; ANIMALS; BENZOPHENONES; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLODEXTRINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCIPIENTS; MICE; MICE, INBRED HRS; PERMEABILITY; SKIN; SKIN ABSORPTION; SOLUBILITY; SOLVENTS; SUNSCREENING AGENTS; THERMODYNAMICS; TIME FACTORS; WATER;

EID: 0036408814     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120014578     Document Type: Article

References (31)

1. Hadgraft, J.; Pugh, W.J. The selection and design of topical and transdermal agents: A review. J. Invest. Derm. 1998, 3, 131-135.
2. Guy, R.H.; Hadgraft, J.; Bucks, D.A. Transdermal drug delivery and cutaneous metabolism. Xenobiotica 1987, 17, 325-343.
3. Barry, B. Penetration enhancers: Mode of action in human skin. CIRD Symposium, Advances in Skin Pharmacology-Skin Pharmacokinetics, 1986.
4. Patel, N.; Highton, P.M. Properties of topical sunscreen formulations. J. Derm. Surg. Oncol. 1992, 18, 316-320.
5. Treffel, P.; Gabard, B. Skin penetration and sun protection factor of ultraviolet filters from two vehicles. Pharm. Res. 1996, 13, 770-774.
6. Hagedorn-Leweke, U.; Lippold, B.C. Absorption of sunscreens and other compounds through human skin in vivo: Derivation of a method to predict maximum fluxes. Pharm. Res. 1995, 12, 1354-1360.
7. Okereke, C.S.; Barat, S.A.; Abdel-Rahman, M.S. Safety evaluation of benzophenone-3 after dermal administration in rats. Tox. Lett. 1995, 80, 61-67.
8. Loftsson, T.; Guomundsdottir, H.; Sigurjonsdottir, J.F.; Sigurosson, H.H.; Sigfusson, S.D.; Masson, M.; Stefansson, E. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int. J. Pharm. 2001, 212, 29-40.
9. Loftsson, T.; Brewster, M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 1996, 85, 1017-1025.
10. Nagase, Y.; Hirata, M.; Wada, K.; Arima, H.; Hirayama, F.; Irie, T.; Kikuchi, M.; Uekama, K. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin. Int. J. Pharm. 2001, 229, 163-172.
11. Williams R.O.; Liu, J. Influence of formulation technique for hydroxypropyl-β-cyclodextrin on the stability of aspirin in HFA 134a. Eur. J. Pharm. Biopharm. 1999, 47, 145-152.
12. Antoniadou-Vyza, E.; Buckton, G.; Michaleas, S.G.; Loukas, Y.; Efentakis, M. The formation of an inclusion complex of methocarbamol with hydroxypropyl-β-cyclodextrin: The effect on chemical stability, solubility and dissolution rate. Int. J. Pharm. 1997, 158, 233-239.
13. Scalia, S.; Villani, S.; Scatturin, A.; Vandelli, M.A.; Forni, F. Complexation of the sunscreen agent, butylmethoxydibenzoylmethane, with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 1998, 175, 205-213.
14. Legendre, J.Y.; Rault, I.; Petit, A.; Luijten, W.; Demuynck, I.; Horvath, S.; Ginot, Y.M.; Cuine, A. Effects of β-cyclodextrins on skin: Implications for transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977. Eur. J. Pharm. 1995, 3, 311-322.
15. Williams, A.C.; Shatri, S.R.S.; Barry, B.W. Transdermal permeation modulation by cyclodextrins: A mechanistic study. Pharm. Dev. Technol. 1998, 3, 283-296.
16. Loftsson, T.; Sigurdardottir, A.M.; Olafsson, J.H. Improved acitretin delivery through hairless mouse skin by cyclodextrin complexation. Int. J. Pharm. 1995, 115, 255-258.
17. Loftsson, T.; Masson, M.; Sigurdsson, H. Cyclodextrins and drug permeability through semi-permeable cellophane membranes. Int. J. Pharm. 2002, 232, 35-43.
18. Kastin, G.; Bowman, L. Electrical analysis of fresh, excised human skin: Comparison with frozen skin. Pharm. Res. 1990, 7, 1141-1146.
19. Pitman, I.; Downes, L. Cattle and sheep skin permeability: Comparison of frozen and reconstituted skin with that of fresh skin. J. Pharm. Sci. 1982, 71, 846.
20. Becket, G.; Schep, L.J.; Tan, M.Y. Improvement of the in vitro dissolution of praziquantel by complexation with α, β, and γ-cyclodextrins. Int. J. Pharm. 1999, 179, 65-71.
21. Higuchi, T.; Connors, K.A. In Advances in Analytical Chemistry and Instrumentation; Reilley, C.N., Ed.; John Wiley & Sons: New York, 1965; 117-212.
22. Loftsson, T.; Frioriksdottir, H.; Thorisdottir, S.; Stefansson, E.; Siguroardottir, A.M.; Guomundsson, O.; Sigthorsson. T. 2-Hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulations. Eur. J. Pharm. Sci. 1994, 1, 175-180.
23. Faucci, M.T.; Mura, P. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified β-cyclodextrins. Drug Dev. Ind. Pharm. 2001, 27, 909-917.
24. Dalmora, M.E.; Dalmora, S.L.; Oliveira, A.G. Inclusion complex of piroxicam and β-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect. Int. J. Pharm. 2001, 222, 45-55.
25. Vitoria, M.; Bentley, B.; Renata, F.; Wilson, S.; Collett, J.H. Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse. J. Pharm. Pharmacol. 1997, 49, 397-402.
26. Siefert, B.; Keipert, S. Influence of alpha-cyclodextrin and hydroxyalkylated β-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine HCl solutions. J. Pharm. Sci. 1997, 86, 716-720.
27. Arima, H.; Miyaji, T.; Irie, T.; Hirayama, F.; Uekama, K. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylacetic acid by β-cyclodextrin derivatives in hydrophilic ointment. Chem. Pharm. Bull. 1996, 44, 582-586.
28. Tanaka, M.; Iwata, Y.; Kouzuki, Y.; Taniguchi, K.; Matsuda, H.; Arima, H.; Tsuchiya, S. Effect of 2-hydroxypropyl-β-cyclodextrin on percutaneous absorption of methyl paraben. J. Pharm. Pharmacol. 1995, 47, 897-900.
29. Loftsson, T.; Masson, M. Cyclodextrins in topical drug formulations: Theory and practice. Int. J. Pharm. 2001, 225, 15-30.
30. Vollmer, U.; Muller, B.W.; Mesens, J.; Wilffert, B.; Peters, T. In vivo skin pharmacokinetics of liarozole: Percutaneous absorption studies with different formulations of cyclodextrin derivatives in rats. Int. J. Pharm. 1993, 99, 51-58.
31. Loftsson, T.; Siguroardottir, A.M. The effect of polyvinylpyrrolidone and hydroxypropyl methylcellulose on HP-β-CD complexation of hydrocortisone and its permeability through hairless mouse skin. Eur. J. Pharm. Sci. 1994, 2, 297-301.